Logo (USPTO, 02/21/2003)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark was filed as Figurative mark on 02/21/2003 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/14/2006.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Figurative mark |
| File reference | 76491276 |
| Register number | 3068626 |
| Application date | February 21, 2003 |
| Publication date | August 3, 2004 |
| Entry date | March 14, 2006 |
Trademark owner
Chiyoda-ku
Tokyo 100-8185
JP
Tokyo 100-8185
JP
Trademark representatives
goods and services
1
Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for scientific laboratory or medical research; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for scientific, laboratory or medical research; host cells for scientific, laboratory or medical research
5
Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for clinical or medical use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for clinical or medical use; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for clinical or medical use; host cells for clinical or medical use; pharmaceuticals, namely, central nervous system depressants; preparations for ophthalmic use, anti-histaminics; cardiotonics; arrhythmia treating agents; diuretics; hypotensors; prophylactic for the treatment of asthma; antitussives and expectorants; stomachics and digestives; antacids; hormones, namely, pituitary hormones for the treatment of infertility; thyroid hormones for the treatment of hyperthyroidism; anabolic hormones for the treatment of a plastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics; analgesics; anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents for treating vitamin deficiencies; anti-coagulants; enzyme preparations for control of malabsorption and diarrhea; anti-cancer preparations; anti-sarcoma preparations; antibiotics and their preparations for the treatment of infectious diseases; antituberculotic agents; influenza vaccines; diphtheria vaccines; tetanus vaccines; gas gangrene vaccines, Japanese encephalitis vaccines; in vitro tetrodotoxines for medical use; antiprotozoals for the treatment of trichomoniasis and dermatophytosis; anthelmintics for the treatment of thread worm and toxoplasmaosis; naturally occurring drugs for treating peptic ulcers; charred drugs for treating peptic ulcers; moxa for treating peptic ulcers; veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use; antiseptics; drugs for arteriosclerosis; oncostatic drugs for the treatment for cancer; multi enzyme digestants for in vivo use; anti fungal antibiotics for treating trichomoniasis and dermatophytosis; antiparkinsonism drugs; minor tranquilizers; and anti anxiety agents; medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; vitamins; anti-bacterial preparations; mucolytic preparations; medicinal preparations for the treatment of peptic ulcers; anti-inflammatory preparations; analgesic preparations; cephalosporin; cocarboxylase preparations; gluthathione preparations; preparations for improving the metabolism and the peripheral circulation; plasma substitutes and extra corporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media; pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
42
Contract development for antibody, fragment of antibody or derivatives of antibody; contract development for cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for host cells
ID: 1376491276